Cutera, Inc. conducted a survey that studied the social toll acne can take on sufferers. The research discovered that 90% of moderate to severe acne sufferers said that having acne-free skin would dramatically change the way they live their life. Cutera paired this survey with the release of AviClear, the first FDA-cleared energy-based device for the treatment of mild, moderate, and severe acne that is now being made available in the U.S. for a limited time.
Other results revealed that many with acne miss moments where first impressions would be made and moments where cameras would be present. According to the study, "One in four moderate to severe acne sufferers have missed over 10 important life moments due to acne, and when acne sufferers do show up for those life moments, they are often wrought with negative feelings and insecurities that keep them from being fully present."
“It doesn't surprise me that the vast majority of acne sufferers change their behaviors when they are experiencing a flare up and have missed out on important life events,” said David J. Goldberg, M.D., J.D. “These survey results are completely in line with what I hear from my patients, who shy away from cameras and stay home when they want to be out with friends, which is why I am so excited to now be able to offer AviClear to those who have long been seeking a safe, effective, and drug-free treatment option.”
As part of the company's limited commercial release, AviClear devices are being sold around the country. Cutera is planning an expansion of the device over the course of 2022.